ARK 每周股评 – 1/5/2021

我们每周都会与投资者分享我们策略中一周内一天内升值或下跌超过15%的股票的周评。我们希望您觉得这篇评论有用。

We share weekly commentaries with investors on stocks in our strategies that have appreciated or dropped more than 15% in a day during the course of the week. We hope you find this commentary useful.

Evogene (EVGN)
+27%Evogene (EVGN), a computational biology company, traded up 27% last Monday. One of its subsidiaries, Lavie Bio – an ag-bio company focused on creating microbiome-based products – updated its product pipeline and announced that LAV211, a bio-stimulant targeting spring wheat, is likely to launch commercially in 2022.

注: 计算生物学公司Evogene(EVGN)上周一交易量上涨27%。其子公司之一的Lavie Bio–一家专注于创造微生物组产品的农业生物公司–更新了其产品管线,并宣布针对春小麦的生物刺激剂LAV211有可能在2022年投入商业化生产。
Arcturus Therapeutics (ARCT)
-54%Arcturus Therapeutics (ARCT), a leading clinical-stage messenger RNA therapy company focused on the development of infectious disease vaccines, closed down approximately 54% last Tuesday after announcing its COVID-19 Phase I/II data. While investors appear to be disappointed that its neutralizing antibodies (nAbs) were lower than the levels associated with competitive vaccines, Arcturus’s vaccine induced a stronger cellular response – importantly T-cells – which could prove more potent and durable against SARS-CoV-2.

注: Arcturus Therapeutics (ARCT) 是一家专注于开发传染病疫苗的领先临床阶段信使RNA疗法公司,在上周二公布其COVID-19 I/II期数据后,收盘下跌约54%。虽然投资者似乎对其中和抗体(nAbs)低于竞争性疫苗的相关水平感到失望,但Arcturus的疫苗诱导了更强的细胞反应–重要的是T细胞–这可能被证明对SARS-CoV-2更有效和更持久。
Pinduoduo (PDD)
+15%Pinduoduo (PDD) jumped 15% last Tuesday after news broke that China would ramp up pressure on Alibaba – the largest e-commerce player in China. Chinese regulators have targeted Alibaba with an anti-monopoly investigation. Pinduoduo is the fastest-growing e-commerce platform in China and, with more than 731 million annual active buyers, the second-largest player.

注: 拼多多 (PDD) 上周二大涨15%,此前有消息称,中国将加大对阿里巴巴–中国最大的电商企业–的压力。中国监管机构已将反垄断调查的矛头指向阿里巴巴。拼多多是中国增长最快的电商平台,并且,拥有超过7.31亿的年度活跃买家,是第二大玩家。
908 Devices (MASS)
-16%908 Devices (MASS), a life-science tools company that focuses on microscale mass spectrometry, traded down 16% last Tuesday, likely a normal correction to its 200%+ surge after going public several weeks ago. ARK believes that 908’s miniaturization of mass spectrometry will accelerate the pace of translational and discovery-stage biological research.

注: 908 Devices (MASS) 是一家专注于微尺度质谱的生命科学工具公司,上周二交易量下降了16%,这可能是对几周前上市后200%以上的涨幅的正常修正。ARK认为,908的质谱微型化将加快转化和发现阶段生物研究的步伐。
LendingClub (LC)
+25%LendingClub (LC) closed up 25% last Thursday after the Office of the Comptroller of the Currency (OCC) approved its Radius Bank acquisition. If the Federal Reserve approves LendingClub’s application to become a bank holding company, the OCC will allow Radius Bank to convert from a federal savings association to a national bank owned by LendingClub.

注: 在货币监理署 (OCC) 批准其收购 Radius 银行后,LendingClub (LC) 上周四收盘上涨25%。如果美联储批准 LendingClub 成为银行控股公司的申请,OCC 将允许 Radius 银行从联邦储蓄协会转变为 LendingClub 拥有的国家银行。

主题测试文章,只做测试使用。发布者:star,转转请注明出处:http://wallstreetgm.com/ark-%e6%af%8f%e5%91%a8%e8%82%a1%e8%af%84-1-5-2021/

发表评论

邮箱地址不会被公开。 必填项已用*标注